A New Augmentation Strategy against Depression Combining SSRIs and the N-terminal Fragment of Galanin (1-15)
Depression is one of the most disabling mental disorders, with the second highest social burden; its prevalence has grown by more than 27% in recent years, affecting 246 million in 2021. Despite the wide range of antidepressants available, more than 50% of patients show treatment-resistant depressio...
Gespeichert in:
Veröffentlicht in: | Current neuropharmacology 2024-10, Vol.23 (3), p.295-309 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!